Cardlytics, Inc. Cash Flow Statement
CDLX|8 years of annual SEC 10-K data (FY2018-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 8 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Operating Cash Flow
$9M
FY2025
Free Cash Flow
$9M
FY2025
Capital Expenditures
$480,000
Cash used for long-term assets
Dividends Paid
N/A
FY2025
Cardlytics, Inc. generated $9M in operating cash flow and $9M in free cash flow in FY2025. Free cash flow margin was 3.8% of revenue.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Negative shareholders equity: Liabilities exceed assets
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$103.5M | -$189.3M | -$134.7M | -$55.4M | -$17.1M | -$53.0M | -$19.6M | -$75.7M |
| Depreciation & Amortization | $25.2M | $25.7M | $26.5M | $7.8M | $4.5M | $3.3M | $3.0M | $4.2M |
| Operating Cash Flow | $9.3M | -$8.8M | -$185.0K | -$7.6M | $11.5M | -$19.0M | -$22.1M | -$32.5M |
| Capital Expenditures | $480.0K | $1.6M | $667.0K | $5.4M | $8.3M | $5.9M | $1.2M | $1.8M |
| Free Cash Flow | $8.8M | -$10.4M | -$852.0K | -$13.0M | $3.2M | -$24.9M | -$23.3M | -$34.3M |
| Share Buybacks | - | $0 | $0 | $0 | - | - | - | - |
| FCF Margin | 3.8% | -3.7% | -0.3% | -7.0% | 1.5% | -16.5% | -17.9% | -30.4% |